Literature DB >> 26126877

IVF for fertility preservation in breast cancer patients--efficacy and safety issues.

M Shapira1, H Raanani, D Meirow.   

Abstract

BACKGROUND: Potential risks on future fertility have become a dominant issue in consultation and management of newly diagnosed young cancer patients. Several fertility preservation strategies are currently available. Of those, ovarian stimulation followed by IVF and embryo cryopreservation is the most established one and is especially applicable in reproductive aged breast cancer patients. AIM: The aim of this study is to provide a comprehensive review on ovarian stimulation and IVF for fertility preservation in newly diagnosed breast cancer patients.
METHODS: Review of relevant literature is available through PubMed and Google scholar.
RESULTS: The use of IVF for fertility preservation in breast cancer patients raises dilemmas regarding efficacy and safety of controlled ovarian stimulation. Among these are the suggested role of malignancy and BRCA mutation in reducing ovarian response to stimulation, strategies designated to protect against hyper-estrogenic state associated with stimulation (co-treatment with tamoxifen or letrozole), and possible adjustments to accommodate oncologic-related time constraints.
CONCLUSION: Ovarian stimulation followed by IVF forms an important fertility preservation strategy for newly diagnosed young breast cancer patients, though live born rates following thawed embryo transfer in these patients are still lacking. Recent advances in controlled ovarian stimulation protocols provide practical options for some of the challenges that breast cancer patients present.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26126877      PMCID: PMC4554381          DOI: 10.1007/s10815-015-0519-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  76 in total

Review 1.  Ovarian antral folliculogenesis during the human menstrual cycle: a review.

Authors:  Angela R Baerwald; Gregg P Adams; Roger A Pierson
Journal:  Hum Reprod Update       Date:  2011-11-08       Impact factor: 15.610

2.  Having children after cancer. A pilot survey of survivors' attitudes and experiences.

Authors:  L R Schover; L A Rybicki; B A Martin; K A Bringelsen
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

3.  Breast cancer incidence trends in European women aged 20-39 years at diagnosis.

Authors:  D F Merlo; M Ceppi; R Filiberti; V Bocchini; A Znaor; M Gamulin; M Primic-Žakelj; P Bruzzi; C Bouchardy; A Fucic
Journal:  Breast Cancer Res Treat       Date:  2012-03-29       Impact factor: 4.872

Review 4.  Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data.

Authors:  Dror Meirow; Eyal Schiff
Journal:  J Natl Cancer Inst Monogr       Date:  2005

5.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

6.  Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Authors:  Dror Meirow; Hila Raanani; Ettie Maman; Shani Paluch-Shimon; Moran Shapira; Yoram Cohen; Irena Kuchuk; Ariel Hourvitz; Jacob Levron; Michal Mozer-Mendel; Masha Brengauz; Hana Biderman; Daphna Manela; Rephael Catane; Jehoshua Dor; Raoul Orvieto; Bella Kaufman
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

7.  Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.

Authors:  Rebecca H Johnson; Franklin L Chien; Archie Bleyer
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

8.  Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.

Authors:  K Oktay; E Buyuk; O Davis; I Yermakova; L Veeck; Z Rosenwaks
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

9.  Multiple approaches for individualized fertility protective therapy in cancer patients.

Authors:  I Demeestere; F Moffa; F Peccatori; C Poirot; E Shalom-Paz
Journal:  Obstet Gynecol Int       Date:  2011-12-29

10.  Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  S Cold; M Düring; M Ewertz; A Knoop; S Møller
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more
  14 in total

1.  [Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].

Authors:  Matthias W Beckmann; Sebastian Findeklee
Journal:  Strahlenther Onkol       Date:  2015-11       Impact factor: 3.621

2.  Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation.

Authors:  David Mark Robertson; Robert B Gilchrist; William Leigh Ledger; Angela Baerwald
Journal:  Womens Health (Lond)       Date:  2016-06-01

3.  Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.

Authors:  Angrit Stachs; Steffi Hartmann; Bernd Gerber
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

Review 4.  Sexuality, fertility and pregnancy following breast cancer treatment.

Authors:  Mary Lopresti; Tina Rizack; Don S Dizon
Journal:  Gland Surg       Date:  2018-08

5.  Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.

Authors:  Molly B Moravek; Rafael Confino; Angela K Lawson; Kristin N Smith; Ralph R Kazer; Susan C Klock; William J Gradishar; Jacqueline S Jeruss; Mary Ellen Pavone
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

6.  Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies.

Authors:  Jovana Lekovich; Alexandre L S Lobel; Joshua D Stewart; Nigel Pereira; Isaac Kligman; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2016-03-04       Impact factor: 3.412

7.  Responses to fertility treatment among patients with cancer: a retrospective cohort study.

Authors:  A V Dolinko; L V Farland; S A Missmer; S S Srouji; C Racowsky; E S Ginsburg
Journal:  Fertil Res Pract       Date:  2018-04-17

8.  Cancer fertility preservation: a report from a Brazilian social program.

Authors:  Caroline Z Berton; Caroline Brogliato; Ivan H Yoshida; Laura T Vellez; Claudia H Suganuma; Emerson B Cordts; Gabriel S Conceição; Caio P Barbosa
Journal:  JBRA Assist Reprod       Date:  2020-07-14

Review 9.  Fertility preservation in patients with BRCA mutation.

Authors:  Suleiman Ghunaim; Ghina Ghazeeri; Dalia Khalife; Hatem A Azim
Journal:  Ecancermedicalscience       Date:  2020-05-06

10.  Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature.

Authors:  Márcia M Carneiro; Ana M Cota; Maria C Amaral; Moisa L Pedrosa; Bruna O Martins; Marcelo H Furtado; Rivia M Lamaita; Marcia C F Ferreira
Journal:  JBRA Assist Reprod       Date:  2018-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.